ADVERTISEMENT
Mayer Brown advises Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, on the financing of the acquisition of Dutscher Group, the European leader in consumables and equipment distribution for R&D laboratories. The transaction, which is expected to close during the first half of 2026, subject to regulatory approvals.
The deal will mark Vivo Capital’s first buyout investment in Europe and underscores the firm’s continued expansion as a global healthcare investor, building on its long-standing leadership across North America and Asia
SPONSORED
